3CHI Story

Founding and Vision

3CHI, pronounced “three-chee,” was founded by a biochemist who had 15 years of experience in product formulation. The inception of the company was inspired by the founder’s firsthand experience with the healing properties of hemp. Recognizing the potential beyond just CBD (cannabidiol), which was the primary focus of the hemp industry at that time, 3CHI aimed to explore and bring to market minor cannabinoids. This innovative approach has significantly influenced the cannabis industry, leading to a growing demand for these lesser-known compounds.

Focus on Minor Cannabinoids

At its formation, the hemp industry predominantly concentrated on CBD, largely overlooking other cannabinoids present in hemp. However, 3CHI’s revolutionary vision included a strong emphasis on minor cannabinoids such as CBN (cannabinol), Delta-8 THC (tetrahydrocannabinol), CBC (cannabichromene), and CBT (cannabicitran). This strategic pivot not only diversified their product offerings but also helped pave the way for an industry shift where minor cannabinoids began to surpass CBD in consumer demand.

Innovations and Product Development

Throughout its history, 3CHI has consistently pushed boundaries within the cannabis sector. The company made headlines by being the first to introduce CBN products to consumers, followed closely by pioneering Delta-8 THC products. Their commitment to innovation did not stop there; they also developed blended cannabinoid products that combine various cannabinoids for enhanced effects. This dedication to research and development has allowed 3CHI to maintain some of the highest purity levels in cannabinoid production.

Patents and Industry Leadership

In addition to their product innovations, 3CHI is actively pursuing multiple patents related to their unique production processes. This focus on maintaining high standards of purity and efficacy positions them as leaders in cannabinoid research and product formulation within the cannabis industry.